MediciNova, Inc. (MNOV) vs PDS Biotechnology Corporation (PDSB)
- MediciNova, Inc. MNOV 1.42 −2.07%
- PDS Biotechnology Corporation PDSB 1.12 −13.85%
MediciNova, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. MediciNova, Inc. and PDS Biotechnology Corporation are of similar size ($72.8M and $71.4M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (0.00% vs −62.5%). Across the 13 metrics below, PDS Biotechnology Corporation leads on 7 and MediciNova, Inc. on 6.
Valuation
Profitability
| Metric | MNOV | PDSB | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 0.00% | 65.16% |
| Operating margin | (1,287.53%) | 0.00% | 0.00% |
| Net margin | (1,168.31%) | 0.00% | 0.00% |
| Free cash flow margin | (991.31%) | 0.00% | 0.00% |
| Return on equity | (25.56%) | (543.97%) | (56.36%) |
| Return on assets | (23.83%) | (136.65%) | (48.04%) |
| Return on invested capital | (62.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack